Liposomal drug delivery systems: from concept to clinical applications
- PMID: 23036225
- DOI: 10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: from concept to clinical applications
Abstract
The first closed bilayer phospholipid systems, called liposomes, were described in 1965 and soon were proposed as drug delivery systems. The pioneering work of countless liposome researchers over almost 5 decades led to the development of important technical advances such as remote drug loading, extrusion for homogeneous size, long-circulating (PEGylated) liposomes, triggered release liposomes, liposomes containing nucleic acid polymers, ligand-targeted liposomes and liposomes containing combinations of drugs. These advances have led to numerous clinical trials in such diverse areas as the delivery of anti-cancer, anti-fungal and antibiotic drugs, the delivery of gene medicines, and the delivery of anesthetics and anti-inflammatory drugs. A number of liposomes (lipidic nanoparticles) are on the market, and many more are in the pipeline. Lipidic nanoparticles are the first nanomedicine delivery system to make the transition from concept to clinical application, and they are now an established technology platform with considerable clinical acceptance. We can look forward to many more clinical products in the future.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Liposomal nanomedicines.Expert Opin Drug Deliv. 2008 Jan;5(1):25-44. doi: 10.1517/17425247.5.1.25. Expert Opin Drug Deliv. 2008. PMID: 18095927 Review.
-
Nanoparticles in drug delivery: past, present and future.Adv Drug Deliv Rev. 2013 Jan;65(1):21-3. doi: 10.1016/j.addr.2012.04.010. Epub 2012 May 9. Adv Drug Deliv Rev. 2013. PMID: 22580334 Review.
-
Liposomal nanomedicines: an emerging field.Toxicol Pathol. 2008 Jan;36(1):21-9. doi: 10.1177/0192623307310960. Toxicol Pathol. 2008. PMID: 18337218
-
Nanocarriers for oral drug delivery.J Drug Target. 2013 Jul;21(6):515-27. doi: 10.3109/1061186X.2013.789033. Epub 2013 Apr 26. J Drug Target. 2013. PMID: 23621127 Review.
-
Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):130-8. doi: 10.1002/wnan.1209. Epub 2013 Jan 17. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013. PMID: 23335566 Review.
Cited by
-
Design and development of nanoprobes radiolabelled with 99mTc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.EJNMMI Radiopharm Chem. 2024 Oct 29;9(1):74. doi: 10.1186/s41181-024-00300-z. EJNMMI Radiopharm Chem. 2024. PMID: 39470937 Free PMC article.
-
Nanotechnology in cancer therapeutics, diagnosis, and management.BioTechnologia (Pozn). 2024 Sep 30;105(3):287-303. doi: 10.5114/bta.2024.141807. eCollection 2024. BioTechnologia (Pozn). 2024. PMID: 39439717 Free PMC article. Review.
-
High-Speed Imaging of Giant Unilamellar Vesicle Formation in cDICE.ACS Omega. 2024 Sep 25;9(41):42278-42288. doi: 10.1021/acsomega.4c04825. eCollection 2024 Oct 15. ACS Omega. 2024. PMID: 39431092 Free PMC article.
-
Liposome-Assisted Drug Delivery in the Treatment of Multiple Sclerosis.Molecules. 2024 Oct 3;29(19):4689. doi: 10.3390/molecules29194689. Molecules. 2024. PMID: 39407617 Free PMC article. Review.
-
Ferulic Acid: A Comprehensive Review.Cureus. 2024 Aug 28;16(8):e68063. doi: 10.7759/cureus.68063. eCollection 2024 Aug. Cureus. 2024. PMID: 39347187 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical